|
TTC19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.937530E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.478760E-01 |
| Normal-vs-Stage2 |
1.990490E-02 |
| Normal-vs-Stage3 |
2.377800E-02 |
| Normal-vs-Stage4 |
2.343100E-03 |
| Stage1-vs-Stage2 |
1.398570E-01 |
| Stage1-vs-Stage3 |
1.245190E-01 |
| Stage1-vs-Stage4 |
7.444100E-02 |
| Stage2-vs-Stage3 |
9.278200E-01 |
| Stage2-vs-Stage4 |
5.138600E-01 |
| Stage3-vs-Stage4 |
4.977600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.848500E-02 |
| Normal-vs-AfricanAmerican |
6.815100E-03 |
| Normal-vs-Asian |
2.937000E-01 |
| Caucasian-vs-AfricanAmerican |
1.041380E-01 |
| Caucasian-vs-Asian |
4.766800E-01 |
| AfricanAmerican-vs-Asian |
7.547800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.446130E-02 |
| Normal-vs-Female |
1.656030E-01 |
| Male-vs-Female |
4.910000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.420100E-03 |
| Normal-vs-Extreme_Weight |
9.285600E-02 |
| Normal-vs-Obese |
3.740200E-02 |
| Normal-vs-Extreme_Obese |
4.730000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.287200E-01 |
| Normal_Weight-vs-Obese |
3.329600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.581600E-01 |
| Extreme_Weight-vs-Obese |
6.525000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.618000E-01 |
| Obese-vs-Extreme_Obese |
7.531000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.938200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.145810E-01 |
| Normal-vs-Age(61-80Yrs) |
2.283800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.335700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.069400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.202200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.237400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.611800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.878500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.470620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.040000E-01 |
| Normal-VS-Type2 PRCC |
2.552500E-04 |
| Normal-VS-KIRP CIMP |
3.598400E-02 |
| Normal-VS-Unclassified PRCC |
9.890400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.356900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.604560E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.308960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.011000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.757800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.918400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82800000000572E-05 |
| Normal-vs-N1 |
1.636230E-01 |
| Normal-vs-N2 |
1.830420E-04 |
| N0-vs-N1 |
2.606800E-01 |
| N0-vs-N2 |
2.070200E-01 |
| N1-vs-N2 |
1.694240E-01 |
|
|
